最新资讯

最新资讯

When Large-Language-Models Make Sense: A Game Changer for Enterprises

At EDBI’s inaugural masterclass in collaboration with NVIDIA, we delved into the world of Large Language Models (LLM) and glimpsed into the opportunities and challenges in its landscape led by Dr. Ettikan K Karuppiah, director and technologist and Dr. Deb Goswani, head of developer programs - big data and analytics at NVIDIA.
A recipe for success: How to thrive in Southeast Asia alternative protein market
Singapore has taken bold steps in accelerating innovation in the agrifood landscape in the recent years. For instance, while global regulators grappled with how to regulate cell-based foods, Singapore Food Agency (SFA) broke the impasse by becoming the first to grant regulatory approval for cell-based meat in 2021.
WalkMe Establishes Asia Pacific Headquarters in Singapore
WalkMe, a leading provider of digital adoption platforms, announced the opening of its Asia Pacific headquarters in Singapore. The office was officially opened by Raphael Sweary, President and Co-founder, WalkMe at an exclusive event with senior executives from EDBI and IMDA.

Moderna Confirms Supply Agreement with the Ministry of Health to Supply Singapore with mRNA Vaccine Against COVID-19 (mRNA-1273)

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today confirmed that the Company concluded an agreement with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support ongoing efforts to secure access to a safe and effective COVID-19 vaccine for the people of Singapore.

Singapore-based EDBI named as Pico investor and strategic partner

NEW YORK, NY – November 13, 2019 – Pico, a leading provider of technology-as-a-service for the financial markets community globally, today announced that EDBI, a global Asian-based Investor, is now a Pico investor and strategic partner.

Startup SG Equity Scheme (Fund-of-funds)

The Startup SG Equity (SSG-E) scheme aims to stimulate private sector investments into innovative and commercially viable Singapore-based technology startups with global market potential. The scheme was enhanced in 2020 to catalyze more private sector investments into Singapore-based Deep Technology startups, and introduced a fund-of-funds modality to attract global venture capital funds with experience in Deep Technology investments.

Inaugural ASEAN New Economy Conference 2020

In partnership with China Renaissance, EDBI co-hosted the inaugural ASEAN New Economy Conference 2020

Artificial intelligence could deliver a US$1 trillion uplift to Southeast Asia’s GDP by 2030

The razor-sharp execution of artificial intelligence (AI) in Southeast Asia could boost the region’s gross domestic product by nearly a US$1 trillion by 2030

Screening Eagle Digital Summit – 9 September 2020

Screening Eagle is pioneering the Inspection Tech industry, bringing together talent to build digital-first, intelligent inspection solutions that secure an AI-powered future of long-term sustainable assets and infrastructure for the public and the asset owners. Join them on 9th September 2020 for Screening Eagle Technologies Digital keynote!

EDBI and SEEDS Capital to provide S$285 million in financing to promising startups to tide through COVID-19 period

EDBI, the corporate investment arm of Economic Development Board, and SEEDS Capital, the investment arm of Enterprise Singapore, will administer the S$285 million Special Situation Fund for Startups (SSFS) to provide financing support for promising startups based in Singapore.

Screening Eagle raises CHF 55 million to protect the built world

Screening Eagle Technologies (SET), a cloud-based technology platform connecting sensors, software, and data for intelligent inspection of assets and infrastructure, is pleased to announce it has raised CHF 55 million in its first institutional round of equity funding.

Singapore-headquartered telehealth start-up Doctor Anywhere closes US$27 million Series B Financing led by Square Peg, EDBI and IHH

SINGAPORE – 31 March 2020 – Doctor Anywhere , a regional tech-led healthcare company headquartered in Singapore, announced today that it has secured a US$27 million Series B financing round led by Square Peg – the largest venture capital fund in Australia, Singapore Government investment arm – EDBI, and IHH Healthcare, a leading international healthcare provider. Rounding out this series of funding are Pavilion Capital and existing shareholder Kamet Capital, bringing Doctor Anywhere’s total capital base to exceed US$40 million.

ElevateBio Closes $170 Million Series B Financing

Cambridge, Mass. – March 30, 2020 – ElevateBio, LLC, a Cambridge-based creator and operator of a portfolio of innovative cell and gene therapy companies, today announced it has closed a $170-million Series B financing that will support and accelerate the company’s next phase of growth.